Further studies of silencing STAT3 specifically in MG would provide insight into whether the activation of STAT3 via IFNAR1 signaling is required for IFNβ-mediated modulation of MG phenotypes in ischemic stroke with delayed tPA treatment. The gene discussed is IFNB1; the disease is ischemic stroke.